首页> 外国专利> A chitosan/TEMPO oxidized cellulose nanofiber hydrogel comprising fk506 for bone therapy and a method for manufacturing the same

A chitosan/TEMPO oxidized cellulose nanofiber hydrogel comprising fk506 for bone therapy and a method for manufacturing the same

机译:一种壳聚糖/速度氧化纤维素纳米纤维水凝胶,包括FK506用于骨治疗和制造方法

摘要

Chitosan / tempo oxidized cellulose nanofiber hydrogel containing fk506 for bone treatment according to an embodiment of the present invention, fk506, chitosan, a gelling agent, and tempo oxidized cellulose nanofibers. When using the method for producing a chitosan/tempo-oxidized cellulose nanofiber hydrogel containing fk506 for bone treatment according to the present invention, the NaHCO 3 content is high, so the sol/gel transition rate increases and the decomposition rate of the CS/TOCNF hydrogel has the effect of lowering In addition, even at a low concentration of fk506, 5 nM, it has the effect of inducing the growth and differentiation of MC3T3-E1 cells, which are progenitor osteoblasts, in vitro (2D culture), so it can be introduced into CS/TOCNF hydrogels, and can be introduced into bone in vivo. There is an advantage that bone regeneration can be induced by introducing a CS/TOCNF hydrogel containing fk506 into the defect site.
机译:壳聚糖/速度氧化纤维素纳米纤维水凝胶含FK506用于根据本发明的一个实施方案,FK506,壳聚糖,胶凝剂和凝聚氧化纤维素纳米纤维的FK506。 当使用含有FK506的壳聚糖/凝乳化纤维素纳米纤维水凝胶的制造方法时,根据本发明的骨处理,NaHCO 3 含量高,因此溶胶/凝胶过渡率增加 CS / TOCNF水凝胶的分解率具有降低的效果,即使在低浓度的FK506,5nm处,它具有诱导MC3T3-E1细胞的生长和分化,这些细胞是祖先的成骨细胞,体外 (2D培养),因此可以将其引入CS / TOCNF水凝胶中,并且可以在体内引入骨中。 存在有利的是,通过将含有Fk506的Cs / TOCNF水凝胶引入缺陷部位来诱导骨再生。

著录项

  • 公开/公告号KR102289206B1

    专利类型

  • 公开/公告日2021-08-13

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020190084795

  • 申请日2019-07-12

  • 分类号A61L27/52;A61K47/36;A61K47/38;A61K9;A61K9/06;A61L27/20;A61L27/54;

  • 国家 KR

  • 入库时间 2022-08-24 20:36:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号